Venture Investment & Partnering (VIP) Forums
One of the WBBA’s objectives is to assist life science companies, entrepreneurs and researchers in bridging the gap between discovery and commercialization. To this end, WBBA has an exciting program called Venture Investment & Partnering (VIP) Forums. VIP Forums present a unique opportunity for local life science entrepreneurs, companies and researchers to meet with quality investors and strategic partners. We invite venture capital firms, corporate venture groups and multinational strategics (VIPs) to Seattle for a two-part event.
First, WBBA hosts a Plenary Session during which the VIP discusses their targets, interests, and investment/partnering strategies, and answers questions from the audience. The Plenary Session is followed by a networking reception. Second, pre-selected organizations present their investment and partnering opportunities to the VIP in a one-on-one setting.
Previous VIPs include LongTech Medical, Johnson & Johnson Development Corp.,Shire Pharmaceuticals, C.R. Bard, MedImmune Ventures and Partnering, H.I.G. BioVentures, Bristol-Myers Squibb, Bayer Healthcare, Merck Global Health Innovation, Takeda Ventures, Johnson & Johnson’s COSAT, BioWa, Inc., Essex Woodlands, NEA and OrbiMed.
Recent VIP Forums:
Eli Lilly and Company
April 15th-16th, 2014
Early consideration applications for One-on-One meetings due March 27th
VIP Forum with Eli Lilly and Company, featuring:
Plenary Session Keynote with CEO Dr. John C. Lechleiter: Reinventing Invention: Advancing Collaboration for Sustainable Bioscience R&D
VIP Forums are made possible by the partnership and generous support of:
If you have questions or are interested in visiting Seattle as a VIP or sponsoring VIP Forums, please contact firstname.lastname@example.org
December 5-6, 2013: Novo Nordisk